Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global overview of multiple sclerosis care units: an international cross-sectional survey.

Frontiers in neurology·2026
Same author

Performances of experts and automated methods on new multiple sclerosis lesions detection: insights from the MSSeg2 challenge.

Scientific reports·2026
Same author

PRIMUS: a precision medicine platform reusing clinical trials and registry data to support treatment selection in multiple sclerosis.

JAMIA open·2026
Same author

Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.

Neurology·2026
Same author

Serum metabolic profile at clinical onset as predictor of multiple sclerosis activity and progression after 5 years.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Generalizable spinal cord multiple sclerosis lesion segmentation across MRI contrasts, protocols, and centers.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Related Experiment Video

Updated: May 8, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Assessment of cognitive dysfunction in multiple sclerosis.

Eric Sartori1, Gilles Edan

  • 1Department of Neurology Rue Henri Le Guillou, CHU Pontchaillou, Rennes, France.

Journal of the Neurological Sciences
|May 9, 2006
PubMed
Summary

Cognitive deficits in multiple sclerosis (MS) can occur early and impact daily life. A brief 30-minute neuropsychological test battery, including the PASAT and memory tests, is recommended for early detection and monitoring of MS-related cognitive changes.

More Related Videos

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

Related Experiment Videos

Last Updated: May 8, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

Area of Science:

  • Neurology
  • Neuropsychology

Background:

  • Cognitive deficits are an early and significant feature of multiple sclerosis (MS).
  • These deficits can be clinically isolated, impacting social activities and reflecting disease progression independent of physical disability.
  • Early detection and monitoring of cognitive changes are crucial for potential therapeutic interventions.

Purpose of the Study:

  • To recommend a brief, sensitive, and clinically practical neuropsychological test battery for assessing cognitive changes in MS.
  • To identify specific tests that are independent of motor or visuo-spatial abilities but sensitive to attention and working memory.
  • To establish guidelines for timing and red flags for cognitive assessment in MS patients.

Main Methods:

  • Review and recommendation of neuropsychological tests suitable for MS.
  • Proposal of a brief battery including the Paced Auditory Serial Addition Test (PASAT), California Verbal Learning Test (CVLT) learning stage, and backward Digit Span.
  • Inclusion of informant questionnaires and timing recommendations post-relapse.

Main Results:

  • A 30-minute neuropsychological battery comprising PASAT, CVLT learning, and backward Digit Span is proposed.
  • Cognitive assessment is recommended at least 8 weeks post-relapse.
  • Specific red flags for screening include mild physical disability with occupational impairment, pathological laughing/crying, advanced age, and low education.

Conclusions:

  • A brief, validated neuropsychological battery can effectively screen for cognitive deficits in MS.
  • Timely and targeted cognitive assessment is essential for managing MS progression and improving patient outcomes.
  • Identifying red flags can facilitate early referral for comprehensive neuropsychological evaluation.